FDA Adverse Event Injury Summary report: N

FREESTYLE LIBRE 3

MDR report key: 13980691 · Received April 1, 2022

Report

Report Number
2954323-2022-10830
Event Type
Injury
Date Received
April 1, 2022
Date of Event
March 10, 2022
Report Date
April 1, 2022
Manufacturer
ABBOTT DIABETES CARE LTD
Product Code
QLG
PMA / PMN Number
N/A
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 0

AT THIS TIME, PRODUCT HAS NOT YET BEEN RETURNED. AN EXTENDED INVESTIGATION HAS BEEN PERFORMED FOR THE REPORTED COMPLAINT. THERE WAS NO INDICATION THAT THE PRODUCT DID NOT MEET SPECIFICATION. THE REPORTED COMPLAINT IS RELATED TO SKIN IRRITATION OR AN ALLERGIC REACTION TO THE PATCH ADHESIVE OF THE FREESTYLE LIBRE SENSOR. DHRS (DEVICE HISTORY RECORD) FOR THE FREESTYLE LIBRE SENSOR AND FREESTYLE LIBRE SENSOR KIT WERE REVIEWED, AND THE DHRS SHOWED THE FREESTYLE LIBRE SENSOR AND FREESTYLE LIBRE SENSOR KIT PASSED ALL TESTS PRIOR TO RELEASE. SHELF LIFE STUDIES, PRODUCT MONITORING, AND DOSE AUDITS WERE PERFORMED DURING PRODUCT DEVELOPMENT AND ON MARKET PERFORMANCE CONTINUES TO BE MONITORED AT ADC. IF THE PRODUCT IS RETURNED, A PHYSICAL INVESTIGATION WILL BE PERFORMED AND A FOLLOW-UP REPORT SUBMITTED. THIS REPORT IS BEING FILED ON AN INTERNATIONAL PRODUCT, MODEL NUMBER 72114-01, WHICH HAS A SIMILAR PRODUCT DISTRIBUTED IN THE U.S., MODEL NUMBER 71992-01. ALL PERTINENT INFORMATION AVAILABLE TO ABBOTT DIABETES CARE HAS BEEN SUBMITTED.

Description of Event or Problem · 0

A CUSTOMER REPORTED A SKIN REACTION AT THE SITE OF THE ADC DEVICE, WITH SYMPTOMS OF REDNESS, INFLAMMATION, AND SWELLING. THE CUSTOMER HAD CONTACT WITH A HEALTHCARE PROFESSIONAL WHO PRESCRIBED UNSPECIFIED ANTIBIOTICS FOR TREATMENT. THERE WAS NO REPORT OF DEATH OR PERMANENT INJURY ASSOCIATED WITH THIS EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1329594 FREESTYLE LIBRE 3 CONTINUOUS GLUCOSE MONITORING SYSTEM QLG ABBOTT DIABETES CARE LTD 72114-01

Patients

Seq Age Sex Outcome Treatment
1 Male Required Intervention